Macdonald, Peter S.
San Francisco VA Medical Center · Amgen (United States) · Duke University · University of California, San Francisco · St Vincent's Hospital Sydney · Estudios Clínicos Latinoamérica · Cytokinetics (United States) · Duke Clinical Research Institute
3 papers on CoChatORCID 0000-0001-5378-2825
Most cited papers
- Verified
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine
Heart Failure Treatment and ManagementCardiomyopathy and Myosin Studies
Cited by 656
- Verified
Efficacy and safety of empagliflozin in the management of diabetes mellitus in heart transplant recipients
Cehic, M. G., Muir, C. A., Greenfield, J. R., Hayward, C., Jabbour, A., Keogh, A., Kotlyar, E., Muthiah, K., & Macdonald, P. S. (2019) · Transplantation Direct
Diabetes Treatment and ManagementTransplantation: Methods and Outcomes
Cited by 55
- Verified
Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement
Arnold, R. H., Tideman, P. A., Devlin, G. P., Carroll, G. E., Elder, A., Lowe, H., Macdonald, P. S., Bannon, P. G., Juergens, C., McGuire, M., et al. (2020) · Heart, Lung and Circulation
COVID-19 and healthcare impactsTelemedicine and Telehealth Implementation
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free